Vimarsana
Biggest News Aggregation in the World

Page 19 - Inducement Plan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Inducement Plan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Inducement Plan Today - Breaking & Trending Today

Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Vimarsana News

Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

30.06.2023 - Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer, today announced it granted inducement awards on June 30, 2023. Seven individuals were hired by ...

Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Vimarsana News

Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Seres Therapeutics, Inc. , a leading microbiome therapeutics company, today announced that on June 7, 2023, the Compensation and Talent Committee of Seres’ board of directors granted... | June 9, 2023

Rhythm Pharmaceuticals Announces New Employment Inducement Grants - Vimarsana News

Rhythm Pharmaceuticals Announces New Employment Inducement Grants

BOSTON, June 06, 2023 -- Rhythm Pharmaceuticals, Inc. , a commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families living with hyperphagia and... | June 6, 2023

ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Vimarsana News

ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01.06.2023 - June 1, 2023 – ImmunoGen, Inc., (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that the compensation committee of the Company’s Board of Directors (the “Compensation ...

ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Vimarsana News

ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

June 1, 2023 – ImmunoGen, Inc., a leader in the expanding field of antibody-drug conjugates for the treatment of cancer, today announced that the compensation committee of the... | June 10, 2023